toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

Specialties

Blood Cancers

The Blood Cancer Center at St. Luke's MSTI in Boise provides treatment for leukemia, lymphoma, multiple myeloma, myelodysplastic disorders, and other less common blood cancers. Our care team also offers autologous and allogeneic bone marrow/stem cell transplant at St. Luke’s Boise. We focus on your quality of life while providing novel therapies, access to clinical trials, and supportive care, close to home.

Call our program coordinators at (208) 381-1679.

  • Facilities & Locations

State-of-the-art treatment close to home; patient-centered care and support; cutting-edge research; and community cancer prevention and education initiatives.


  • Location & Contact Info

    100 E. Idaho St.
    Boise, ID 83712
    (208) 381-2711

Providers

  • Medical Oncology

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Mallori Hooker, RN, MSN, NP-C, AOCNP works in medical oncology/hematology. She is nationally certified as an advanced oncology nurse practitioner from the Oncology Nursing Society, and is a member of the American Academy of Nurse Practitioners. She earned her bachelor's degree in nursing from the University of Oklahoma and her master's degree in nursing from Texas Woman's University.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    William Kreisle, MD is the medical director of St. Luke's MSTI's Blood and Marrow Transplant program. Dr. Kreisle earned his bachelor's degree from Stanford University.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Finn Petersen, MD became involved in the first bone marrow transplants (BMT) in Denmark while in medical school, and after medical school orchestrated the first BMT done for acute leukemia in Denmark. After his fellowship, he joined the faculty at the Fred Hutchinson Cancer Research Center in Seattle and rose to the rank of assistant professor. Afterward, Dr. Petersen accepted a position as full professor at the University of Utah. While there he served as medical director and later program director of the Blood and Marrow Transplant Program, which encompassed the University of Utah's and Intermountain Healthcare's adult BMT programs as well as a pediatric BMT program at Primary Children's Medical Center. He later consolidated adult BMT at the Intermountain Healthcare's LDS Hospital, developing an integrated BMT and hematological malignancy program (blood cancer), focusing on acute leukemia care. In 2015, Dr. Petersen was named one of Utah's Health Care Heroes for his work in establishing and growing a hematological malignancy center of excellence within Intermountain Healthcare.

    Dr. Petersen is currently working to develop and lead an allogenic (donor) blood and marrow transplant program at St. Luke's Mountain States Tumor Institute as part of our new "heme-malignancy" (blood cancer) program.

    Dr. Petersen is internationally known for his long-standing work focusing on complications related to hematopoietic stem cell transplantation, and is an author and co-author of over 180 peer reviewed scientific publications, books, or book chapters. He is a frequent invited speaker at national and international conferences on topics of infections and treatment-related complications in blood and marrow transplantation and acute leukemia treatment.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Jessica Thibault, MD is an oncologist and hematologist who cares for patients with all cancer types and blood disorders. She has special interests in breast cancer, ovarian cancer, and lung cancer.

    Availability

    Accepting new patients
  • Biography

    Travis G. Williams, DO has a special interest in malignant hematology. During his residency, he researched, presented, and published articles on donor-transmitted non-leukemic promyelocytic sarcoma, acute myeloid leukemia, metastic papillary renal cell carcinoma, and cancer medicine rate of complete diagnostic testing. He also earned Chief Fellow and Resident of the Year awards.

    Dr. Williams earned his bachelor's degree in biology from Idaho State University. He is a member of the American College of Physicians, the American Society of Clinical Oncology, and the American Society of Hematology. He currently chairs a team of IT experts and serves as the St. Luke's MSTI IT Medical Director. In his free time, Dr. Williams enjoys the outdoors and spending time with his family.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Michele L. Winslow, RN, MSN, FNP works in medical oncology/hematology. She is nationally certified as a family nurse practitioner by the American Academy of Nurse Practitioners. She earned her bachelor's degree in biochemistry from Colorado College and her master's degree in nursing from Seattle University.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Norman Zuckerman, MD has special interest in anemias and genitourinary cancers. He continues to be passionate about oncology, especially as newer targeted therapies and symptom control medicines are prolonging life and improving quality of life for his patients. As the director of the Integrative Medicine program at St. Luke’s MSTI, Dr. Zuckerman considers all options – conventional and alternative – worthy of discussion.

    Availability

    Accepting new patients
  • Medical Oncology

    Biography

    Dan Zuckerman, MD is the medical director of St. Luke’s Mountain States Tumor Institute. His special interests include gastrointestinal cancers and colorectal cancer.

    Availability

    Accepting new patients

Procedures & Treatments

  • We offer autologous transplants (using your own stem cells) and allogeneic transplants (using cells from a matched donor).
  • Extracorporeal photopheresis is a type of treatment that can be used for patients with problems associated with cutaneous T-cell lymphoma.

  • Plasma exchange removes plasma from a patient's blood and replaces it with donor plasma before it is returned to the body. 

Supportive Oncology

Treating cancer successfully goes beyond a focus on the disease itself.

At St. Luke's MSTI, we understand that attention to your overall well-being will help promote healing and improve your quality of life. Our supportive oncology team works together closely to help you:

  • Take a more active role in treatment and survivorship
  • Improve your quality of life
  • Manage treatment side effects and symptoms (including pain, nausea, and insomnia)
  • Reduce anxiety and stress
  • Provide a sense of overall well-being

Articles & Resources

  • showing 1 of 1
  • Blog Post

    St. Luke's MSTI's Spirit of Innovation